Publications by authors named "G Manos"

Correction for 'From photocatalysis to photon-phonon co-driven catalysis for methanol reforming to hydrogen and valuable by-products' by Hui Wang , , 2025, https://doi.org/10.1039/d4cs00551a.

View Article and Find Full Text PDF
Article Synopsis
  • Hydrogen energy is crucial for transitioning from fossil fuels to low carbon alternatives, but effective storage and transportation technologies are still needed.
  • Methanol is highlighted as a suitable liquid hydrogen storage medium due to its high hydrogen content, ease of transport, and low toxicity, making photocatalytic hydrogen release from methanol a key research area.
  • The review discusses recent advancements in photocatalysts, mechanisms, and innovative reactor designs, particularly focusing on combining photocatalysis with thermal processes to improve methanol reforming efficiency.
View Article and Find Full Text PDF

Background And Aim: Continuous glucose monitoring systems (CGMs) have been commercially available since 1999. However, automated insulin delivery systems may benefit from real-time inputs in addition to glucose. Continuous multi-analyte sensing platforms will meet this area of potential growth without increasing the burden of additional devices.

View Article and Find Full Text PDF

Introduction: Toxic gain-of-function () variants contribute to the development of proteinuric nephropathies collectively referred to as APOL1-mediated kidney disease (AMKD). Despite standard-of-care treatments, patients with AMKD experience accelerated progression to end-stage kidney disease. The identification of two variants as the genetic cause of AMKD inspired development of inaxaplin, an inhibitor of APOL1 channel activity that reduces proteinuria in patients with AMKD.

View Article and Find Full Text PDF
Article Synopsis
  • Scientists studied how well the MiniMed 780G worked for people in Australia with type 1 diabetes compared to the MiniMed 670/770G over a couple of years.
  • They found that those using the MiniMed 780G had better control over their blood sugar levels, meaning they spent more time in the right range and less time with high blood sugar.
  • After switching from 670/770G to 780G, users improved their blood sugar control even more, and this improvement lasted for a year.
View Article and Find Full Text PDF